Recent Updates
Recently added Catalysts

AquaBounty Technologies, Inc.

AQBFDA catalysts, PDUFA dates & pipeline intelligence
$1.05
▲ +0.08 · +7.78%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full AQB financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $0.7052W HIGH $2.95
Volume
110.36 K
Value Traded
1.60 M
Short % Float
2.62%
+6.5%Week
-5.3%1 Month
+9.43%3 Month
+4.57%6 Month
-99.08%5 Year
+583.96%All Time

Cash Data

Unlock AQB cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
5.40 M
EPS (TTM)
-5.14
P/E Ratio
-0.19
Ent. Value
8.51 M
Total Shares
5.15 M
Float Shares
5.12 M
Insiders
0.52%
Institutions
9.40%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every AQB catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

AQB Catalyst Timeline

Dated clinical, regulatory and corporate events for AquaBounty Technologies, Inc.

Unlock the full AQB catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How AQB actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
-Example Drug Phase 3 data readout Phase 3
Unlock all AQB historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

AquaBounty Technologies, Inc. is not a drug developer. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every AQB program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every AQB trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock AQB insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Myers Gail SharpsDirectorBuy 10,000 10,426 held$0.89 12/23/2022
Unlock the full AQB insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in AQB

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in AQB for Q2 2026.
Unlock every fund holding AQB
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in AQB
Shares held by hedge funds each quarter, and who bought or sold.

AQB Institutional Ownership Trends

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock AQB option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live AQB option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock AQB options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How AQB ranks across every disease it competes in

Competitive Position is a premium feature
See how AQB ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

AQB News

AQB
Sep 15, 2026
AQBGeneral

AquaBounty Announces Engagement of Colliers as Exclusive Agent for its Ohio Property

AquaBounty Technologies, Inc. has appointed Colliers as the exclusive real estate agent for its Pioneer, Ohio property. This decision is part of a broader strategic review aimed at maximizing shareholder value. The property features significant infrastructure assets that may appeal to various industrial sectors. However, the company cautions that there is no guarantee of a successful transaction.

Read more →

About AquaBounty Technologies, Inc.

Harvard, MA 3 employees aquabounty.com
Headquarters233 AYER ROAD SUITE 4, HARVARD, MA, 01451
Founded1991
BIOPHARMAWATCH ELITE PLUS
Trade the next AQB catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime